The study aimed to evaluate the immune response, its effect on the coagulant system and the outcome of infection with COVID-19 in two groups (convalescent & severe patients) and healthy individuals groups, 88 blood samples were collected (30 for convalescent and 30 for severe) and 28 for control. All patients with age range (19-70) years with COVID-19 mild and severe symptoms, attended at Ramadi city hospitals, from April 2020 to August 2020, (ELISA) technique was carried out to assess the serum levels of (IL-23 and IL-27) in addition to assess some of the coagulant factors such as ferritin, D-Dimer, CBC, Viral load (Anti SARS CoV-2 antibodies IgM and IgG), C-reactive protein and Erythrocyte sedimentation rate. The results showed that platelet observed decreasing levels in two patient groups (convalescent and severe compare with control). IgM recorded the high levels in severe cases which IgG high in convalescent cases, WBCs, Lymphocyte, Monocyte recorded a decreased count in severe and with no difference between convalescent and control, while Neutrophil count recorded a slight increase in convalescent when compared to controls, the cytokine IL-23 showed a highly significant increase in extreme and a significant increase in convalescent. Also, IL-27 recorded highly significant differences in severe and significant increases in convalescent compare with control. The coagulant factor system (ferritin, D-Dimer, ESR, and CRP) recorded a highly significant increase in severe compare with control, while in convalescent recorded a slight increase in serum levels of ESR and CRP with no difference in ferritin serum level, except D-Dimer which recorded a highly significant difference as compared with control, finally regard to gender male recorded the highest rate of infection as compared with female.
Published in | Advances in Bioscience and Bioengineering (Volume 11, Issue 2) |
DOI | 10.11648/j.abb.20231102.11 |
Page(s) | 21-26 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2023. Published by Science Publishing Group |
COVID-19, Immunological, Hematological, IL-23, IL-27
[1] | Wu, F.; Zhao, S.; Yu, B.; Chen, Y. M.; Wang, W.; Song, Z. G.; Hu, Y.; Tao, Z. W.; Tian, J. H.; Pei, Y. Y.; and Yuan, M. L. (2020) A new coronavirus associated with human respiratory disease in China. Nature, 579 (7798): 265-269. |
[2] | Ciotti, M.; Ciccozzi, M.; Terrinoni, A.; Jiang, W. C.; Wang, C. B. and Bernardini, S. (2020). The COVID-19 pandemic. Crit Rev Clin Lab Sci, 57 (6): 365-388. |
[3] | Chow, E. J., Uyeki, T. M. and Chu, H. Y. (2023). The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol. 21 (3): 195-210. |
[4] | Al-Malkey, M. K. and Al-Sammak, M. A. (2020). Incidence of the COVID-19 in Iraq–Implications for travellers. Travel med infect dis, 38, p. 101739. |
[5] | Cavanaugh, D. Coronaviruses and toroviruses. In: Zuckerman AJ, Banatvala JE, Pattinson JR, Griffiths P, Schoub B, eds. (2004). Principles and practice of clinical virology, 5th edn. London, UK: John Wiley & Sons, 379–97. |
[6] | Wu, L. P.; Wang, N. C.; Chang, Y. H. (2007). Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis, 13 (10): 1562–64. |
[7] | Li, G.; Fan, Y.; Lai, Y.; Han, T.; Li, Z.; Zhou, P.; Pan, P.; Wang, W.; Hu, D.; Liu, X. and Zhang, Q. (2020). Coronavirus infections and immune responses. J med virol, 92 (4): 424-432. |
[8] | Panigada, M.; Bottino, N.; Tagliabue, P.; Grasselli, G.; Novembrino, C.; Chantarangkul, V. (2020). Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost., 18 (7), 1738–42. |
[9] | Tait Wojno, E. D.; Hunter, C. A.; Stumhofer, J. S. (2019). The immune-biology of the interleukin-12 family: Room for discovery. Immunity, 50 (4): 851–870. |
[10] | Kwock, J. T.; Handfield, C.; Suwanpradid, J.; Hoang, P.; McFadden, M. J.; Labagnara, K. F.; Floyd, L.; Shannon, J.; Uppala, R.; Sarkar, M. K. and Gudjonsson, J. E.. (2020). IL-27 signaling activates skin cells to induce innate antiviral proteins and protects against Zika virus infection. Sci Adv, 6 (14): 3245. |
[11] | Hotchkiss, R. S and Opal, S. M. (2020). Activating Immunity to Fight a Foe - A New Path. N Engl J Med, 382 (13): 1270-1272. |
[12] | Benedict, C. A. (2003). Viruses and the TNF-related cytokines, an evolving battle. Cytokine Growth Factor Rev, 14 (3-4): 349–357. |
[13] | Yang, B.; Suwanpradid J.; Sanchez-Lagunes, R.; Choi, H. W.; Hoang, P.; Wang, D.; Abraham, S. N.; MacLeod, A. S. (2017). IL-27 facilitates skin wound healing through induction of epidermal proliferation and host defense. J. Invest. Dermatol, 137 (5): 1166–1175. |
[14] | Morishima, N.; Owaki, T.; Asakawa, M.; Kamiya, S.; Mizuguchi, J.; Yoshimoto, T. (2005). Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27. J. Immunol., 175 (3): 1686–1693. |
[15] | Harker, J. A.; Wong, K. A.; Dallari, S.; Bao, P.; Dolgoter, A.; Jo, Y.; Wehrens, E. J.; Macal, M. and Zuniga, E. I. (2018). Interleukin-27R signaling mediates early viral containment and impacts innate and adaptive immunity after chronic lymphocytic chorio -meningitis virus infection. J. Virol, 92 (12): e02196-17. |
[16] | Fakruddin, J. M.; Lempicki, R. A.; Gorelick, R. J.; Yang, J.; Adelsberger, J. W.; Garcia-Pineres, A. J.; Pinto, L. A.; Lane, H. C.; Imamichi, T. (2007). Noninfectious papilloma virus-like particles inhibit HIV-1 replication: Implications for immune control of HIV-1 infection by IL-27. Blood, 109 (5), 1841–1849. |
[17] | Briese, T.; Hatalski, C. G.; Kliche, S.; Park, Y. S. and Lipkin, W. I. (1995). Enzyme-linked immunosorbent assay for detecting antibodies to Borna disease virus-specific proteins. J of clinic microb, 33 (2): 348-351. |
[18] | Woo, P. C.; Lau, S. K.; Wong, B. H.; Chan, K. H.; Chu, C. M.; Tsoi, H. W.; Huang, Y.; Peiris, J. M. and Yuen, K. Y. (2004). Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus. Clin. Vaccine Immunol., 11 (4): 665-668. |
[19] | Wool, G. D. and Miller, J. L. (2021). The impact of COVID-19 disease on platelets and coagulation. Pathobiology, 88 (1), 15-27. |
[20] | Rohlfing, A. K.; Rath, D.; Geisler, T. and Gawaz, M. (2021). Platelets and COVID-19. Hämostaseologie, 41, 379-385. |
[21] | Yeh, K. M., Chiueh, T. S., Siu, L. K., Lin, J. C., Chan, P. K., Peng, M. Y., Wan, H. L., Chen, J. H., Hu, B. S., Perng, C. L. and Lu, J. J. (2005). Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital. Journal of Antimicrobial Chemotherapy, 56 (5), 919-922. |
[22] | Anthony, D., Etienne, F., Mahary, L. R., Grégorie, L., Damien, V., Anne-Laure, S. S., Claude, G., Axelle, S. M., Marie-Christine, J. B., Loïc, R. and Philippe, G. (2020). Serological surveys in Reunion Island of the first hospitalized patients revealed that long-lived immunoglobulin G antibodies specific against SARS-CoV2 virus are rapidly vanishing in severe cases. medrxiv, 2020-05. |
[23] | Sun, Y.; Zhou, J. and Ye, K. (2021). White blood cells and severe COVID-19: a Mendelian randomization study. J Pers Med, 11 (3): 195. |
[24] | Shin, H. S.; Kim, Y.; Kim, G.; Lee, J. Y.; Jeong, I.; Joh, J. S.; Kim, H.; Chang, E.; Sim, S. Y.; Park, J. S. and Lim, D. G. (2019). Immune responses to Middle East respiratory syndrome coronavirus during the acute and convalescent phases of human infection. Clin Infect Dis, 68 (6): 984-992. |
[25] | Drappier, M.; Michiels T. (2015). Inhibition of the OAS/RNase L pathway by viruses. Curr. Opin. Virol, 15, 19–26. |
[26] | Lippi, G.; Plebani, M. (2020). Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med, 58 (7): 1131–4. |
[27] | Han, H.; Yang, L.; Liu, R.; Liu, F.; Wu, K. L.;, Li, J. (2020). Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med, 58 (7): 1116–20. |
[28] | Helms, J.; Tacquard, C.; Severac, F.; Leonard-Lorant, I.; Ohana, M.; Delabranche, X.; Merdji, H.; Clere-Jehl, R.; Schenck, M.; Fagot Gandet, F. and Fafi-Kremer, S. (2020). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive care med, 46 (6), 1089-1098. |
[29] | Lippi, G.; Mullier, F. and Favaloro, E. J. (2023). D-dimer: Old dogmas, new (COVID-19) tricks. Clin. Chem. Lab. Med, 61 (5): 841-850. |
[30] | Yang, J.; Yang, M.; Xu, F.; Li, K.; Lee, S. K.; Ng, P. C.; Tam, J. S.; Yuen, P. M. and Fok, T. F., (2003). Effects of oxygen-induced lung damage on megakaryocytopoiesis and platelet homeostasis in a rat model. Pediatric research, 54 (3): 344-352. |
[31] | Li, Q.; Cao, Y.; Chen, L.; Wu, D.; Yu, J.; Wang, H.; He, W.; Chen, L.; Dong, F.; Chen, W. and Chen, W. (2020). Hematological features of persons with COVID-19. Leukemia, 34 (8): 2163-2172. |
[32] | Jin, J. M.; Bai, P.; He, W.; Wu, F.; Liu, X. F.; Han, D. M.; Liu, S. and Yang, J. K. (2020). Gender differences in patients with COVID-19: focus on severity and mortality. Frontiers in public health, 152. |
APA Style
Hazima Mossa Alabassi, Dhyauldeen Aftan AlHayani, Omar Ismael Aljuamili, Anwar Khalil Ismael. (2023). The Role of Some Immunological and Hematological Aspects in Patients Infected with COVID-19 in Al-Anbar Province. Advances in Bioscience and Bioengineering, 11(2), 21-26. https://doi.org/10.11648/j.abb.20231102.11
ACS Style
Hazima Mossa Alabassi; Dhyauldeen Aftan AlHayani; Omar Ismael Aljuamili; Anwar Khalil Ismael. The Role of Some Immunological and Hematological Aspects in Patients Infected with COVID-19 in Al-Anbar Province. Adv. BioSci. Bioeng. 2023, 11(2), 21-26. doi: 10.11648/j.abb.20231102.11
AMA Style
Hazima Mossa Alabassi, Dhyauldeen Aftan AlHayani, Omar Ismael Aljuamili, Anwar Khalil Ismael. The Role of Some Immunological and Hematological Aspects in Patients Infected with COVID-19 in Al-Anbar Province. Adv BioSci Bioeng. 2023;11(2):21-26. doi: 10.11648/j.abb.20231102.11
@article{10.11648/j.abb.20231102.11, author = {Hazima Mossa Alabassi and Dhyauldeen Aftan AlHayani and Omar Ismael Aljuamili and Anwar Khalil Ismael}, title = {The Role of Some Immunological and Hematological Aspects in Patients Infected with COVID-19 in Al-Anbar Province}, journal = {Advances in Bioscience and Bioengineering}, volume = {11}, number = {2}, pages = {21-26}, doi = {10.11648/j.abb.20231102.11}, url = {https://doi.org/10.11648/j.abb.20231102.11}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.abb.20231102.11}, abstract = {The study aimed to evaluate the immune response, its effect on the coagulant system and the outcome of infection with COVID-19 in two groups (convalescent & severe patients) and healthy individuals groups, 88 blood samples were collected (30 for convalescent and 30 for severe) and 28 for control. All patients with age range (19-70) years with COVID-19 mild and severe symptoms, attended at Ramadi city hospitals, from April 2020 to August 2020, (ELISA) technique was carried out to assess the serum levels of (IL-23 and IL-27) in addition to assess some of the coagulant factors such as ferritin, D-Dimer, CBC, Viral load (Anti SARS CoV-2 antibodies IgM and IgG), C-reactive protein and Erythrocyte sedimentation rate. The results showed that platelet observed decreasing levels in two patient groups (convalescent and severe compare with control). IgM recorded the high levels in severe cases which IgG high in convalescent cases, WBCs, Lymphocyte, Monocyte recorded a decreased count in severe and with no difference between convalescent and control, while Neutrophil count recorded a slight increase in convalescent when compared to controls, the cytokine IL-23 showed a highly significant increase in extreme and a significant increase in convalescent. Also, IL-27 recorded highly significant differences in severe and significant increases in convalescent compare with control. The coagulant factor system (ferritin, D-Dimer, ESR, and CRP) recorded a highly significant increase in severe compare with control, while in convalescent recorded a slight increase in serum levels of ESR and CRP with no difference in ferritin serum level, except D-Dimer which recorded a highly significant difference as compared with control, finally regard to gender male recorded the highest rate of infection as compared with female.}, year = {2023} }
TY - JOUR T1 - The Role of Some Immunological and Hematological Aspects in Patients Infected with COVID-19 in Al-Anbar Province AU - Hazima Mossa Alabassi AU - Dhyauldeen Aftan AlHayani AU - Omar Ismael Aljuamili AU - Anwar Khalil Ismael Y1 - 2023/07/26 PY - 2023 N1 - https://doi.org/10.11648/j.abb.20231102.11 DO - 10.11648/j.abb.20231102.11 T2 - Advances in Bioscience and Bioengineering JF - Advances in Bioscience and Bioengineering JO - Advances in Bioscience and Bioengineering SP - 21 EP - 26 PB - Science Publishing Group SN - 2330-4162 UR - https://doi.org/10.11648/j.abb.20231102.11 AB - The study aimed to evaluate the immune response, its effect on the coagulant system and the outcome of infection with COVID-19 in two groups (convalescent & severe patients) and healthy individuals groups, 88 blood samples were collected (30 for convalescent and 30 for severe) and 28 for control. All patients with age range (19-70) years with COVID-19 mild and severe symptoms, attended at Ramadi city hospitals, from April 2020 to August 2020, (ELISA) technique was carried out to assess the serum levels of (IL-23 and IL-27) in addition to assess some of the coagulant factors such as ferritin, D-Dimer, CBC, Viral load (Anti SARS CoV-2 antibodies IgM and IgG), C-reactive protein and Erythrocyte sedimentation rate. The results showed that platelet observed decreasing levels in two patient groups (convalescent and severe compare with control). IgM recorded the high levels in severe cases which IgG high in convalescent cases, WBCs, Lymphocyte, Monocyte recorded a decreased count in severe and with no difference between convalescent and control, while Neutrophil count recorded a slight increase in convalescent when compared to controls, the cytokine IL-23 showed a highly significant increase in extreme and a significant increase in convalescent. Also, IL-27 recorded highly significant differences in severe and significant increases in convalescent compare with control. The coagulant factor system (ferritin, D-Dimer, ESR, and CRP) recorded a highly significant increase in severe compare with control, while in convalescent recorded a slight increase in serum levels of ESR and CRP with no difference in ferritin serum level, except D-Dimer which recorded a highly significant difference as compared with control, finally regard to gender male recorded the highest rate of infection as compared with female. VL - 11 IS - 2 ER -